'Living drugs' target CD70 in advanced renal tumors

被引：0
|
作者：
Wagner, Kilian [1 ]
Siska, Peter J. [1 ]
机构：
[1] Univ Hosp Regensburg, Dept Internal Med Hematol & Med Oncol 3, Regensburg, Germany
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2024年 / 45卷 / 09期
关键词：
D O I：
10.1016/j.tips.2024.07.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Cellular therapies against solid tumors face three major barriers: low persistence, insufficient specificity, and high costs. In a recent study, Pal et al. tackle these challenges in kidney cancer by using novel, 'persistence-tuned' allogeneic chimeric antigen receptor (CAR) T cells directed against a stable antigen.
引用
收藏
页码：757 / 759
页数：3
相关论文
共 50 条
  • [41] THE ROLE OF CD70 IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS
    Yoo, Su-Jin
    Kang, Seong Wook
    Kim, Jinhyun
    Yoo, In Seol
    Park, Chan Keol
    Lee, Ha-Reum
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1515 - 1516
  • [42] CD70 REPRESENTS THE HUMAN LIGAND FOR CD27
    HINTZEN, RQ
    LENS, SMA
    KOOPMAN, G
    PALS, ST
    SPITS, H
    VANLIER, RAW
    INTERNATIONAL IMMUNOLOGY, 1994, 6 (03) : 477 - 480
  • [43] The CD27–CD70 axis in osteoclast development
    Maria Papatriantafyllou
    Nature Reviews Immunology, 2013, 13 (8) : 548 - 548
  • [44] Unlocking the potential of CD70 as a therapeutic target in non-small cell lung cancer
    Jacobs, Julie
    Pauwels, Patrick
    Rolfo, Christian
    Lardon, Filip
    Deschoolmeester, Vanessa
    Deben, Christophe
    Van den Bossche, Jolien
    Zwaenepoel, Karen
    Hermans, Christophe
    Silence, Karen
    Thibault, Alain
    CANCER RESEARCH, 2015, 75
  • [45] Immune escape in renal cell carcinomas by CD70 mediated apoptosis in T-lymphocytes?
    Junker, K.
    Diegmann, J.
    Von Eggeling, F.
    Loncarevic, I.
    Schubert, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 32 - 32
  • [46] CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia
    Riether, Carsten
    Schurch, Christian M.
    Buhrer, Elias D.
    Hinterbrandner, Magdalena
    Huguenin, Anne-Laure
    Hoepner, Sabine
    Zlobec, Inti
    Pabst, Thomas
    Radpour, Ramin
    Ochsenbein, Adrian F.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (02): : 359 - 380
  • [47] CD70 HIT T cells overcome tumor antigen heterogeneity in renal cell carcinoma
    Hanina, Sophie A.
    Lopez, Michael
    Zhao, Huiyong
    Vinagolu, Rajasekhar
    Kotecha, Ritesh
    Hakimi, A. Ari
    Healey, John H.
    Mansilla-Soto, Jorge
    Sadelain, Michel
    CANCER RESEARCH, 2023, 83 (07)
  • [48] CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli
    Itani, Hana A.
    Xiao, Liang
    Saleh, Mohamed A.
    Wu, Jing
    Pilkinton, Mark A.
    Dale, Bethany L.
    Barbaro, Natalia R.
    Foss, Jason D.
    Kirabo, Annet
    Montaniel, Kim R.
    Norlander, Allison E.
    Chen, Wei
    Sato, Ryosuke
    Navar, L. Gabriel
    Mallal, Simon A.
    Madhur, Meena S.
    Bernstein, Kenneth E.
    Harrison, David G.
    CIRCULATION RESEARCH, 2016, 118 (08) : 1233 - 1243
  • [49] Effects of CD70 and CD11a in Immune Thrombocytopenia Patients
    Ma, Li
    Zhou, Zeping
    Jia, Hairong
    Zhou, Hu
    Qi, Aiping
    Li, Huiyuan
    Wang, Hongmei
    Zhang, Lei
    Yang, Renchi
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (04) : 632 - 642
  • [50] CD70 antibody based drugs: two different mechanisms of action for the treatment of multiple cancer types
    Terrett, Jonathan A.
    Pan, Chin
    Gangwar, Sanjeev
    Lu, Lisheng
    Chen, Liang
    Rao, Chetana
    Huber, Mary
    Sattari, Peter
    Do, Mary
    Dai, Rory
    Chong, Colin
    Soderberg, Carol
    Li, Hao
    Sufi, Bilal
    Boyd, Sharon
    Huang, Haichun
    Zhang, Jun
    Meaddough, Erika
    Guerlavais, Vincent
    Horgan, Killian
    Sharkov, Nick
    Cardarelli, Pina
    King, David
    Yao, Dapeng
    Pogue, Sarah
    CANCER RESEARCH, 2006, 66 (08)
12345